1.
2.
FDA Approves Replimune’s Melanoma Drug on Third Attempt
(feeds.content.dowjones.io)
3.
FDA Approves First mRNA Flu Shot
(slashdot.org)
4.
Dataset: Dead mental health startups, 2000-2026, coded on 18 fields
(news.ycombinator.com)
5.
A Daily GLP-1 Pill Could Curb Heavy Drinking
(gizmodo.com)
6.
Can long COVID be prevented? Two drugs finally show promise
(feeds.nature.com)
7.
8.
Clinical failure rates over the decades: yikes
(news.ycombinator.com)
9.
Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
(feeds.content.dowjones.io)
10.
11.
12.
13.
Cybercriminals Flock to Healthcare Businesses as Attacks Surge
(darkreading.com)
14.
15.
Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet
(feeds.content.dowjones.io)
16.
Healthy but Sedentary People Show Early Decline in Cellular Energy Production
(news.ycombinator.com)
17.
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
(feeds.nature.com)
18.
19.
Why were Covid vaccine trials so fast?
(news.ycombinator.com)
20.
InSilico Is on a Mission: Be No. 1 in China, Create ‘God Drug’ With AI
(feeds.content.dowjones.io)
21.
Close the gap in pediatric genomic care
(feeds.feedburner.com)
22.
23.
24.
Novo Nordisk Breach Highlights Software Development Pipeline Risk
(darkreading.com)
25.
Hospitals and universities repurposing drugs at lower cost
(news.ycombinator.com)
26.
Hospitals and universities repurposing drugs at 90% lower cost
(news.ycombinator.com)
27.
A mosaic of whole-body representations on the human precentral gyrus
(feeds.nature.com)
28.
Humans aren’t great at identifying ADHD. But AI is
(feeds.feedburner.com)
29.
Nvidia Is Developing an AI Healthcare Model With Startup Abridge
(feeds.content.dowjones.io)
30.
Today's top topics:
dark